Latest Breaking News On - Product revenue grew - Page 1 : comparemela.com

Esperion Reports First Quarter 2024 Financial Results

– Q1 Total Revenue Grew 467% Y/Y to $137.7 Million, Reflecting Strong Growth Globally – – Q1 U.S. Net Product Revenue Grew 46% Y/Y to $24.8 Million – – Q1 Retail Prescription Equivalents.

Czech republicTiffany aldrichDaiichi sankyo europeSheldon koenigEsperion therapeutics incEuropean commission decision for expanded labelsNational health insuranceExchange commissionEuropean commissionEuropean medical agencyDaiichi sankyo companyCommittee for medical products human useRevenue grewReflecting strong growth globallyProduct revenue grewPrescription equivalents grew

Esperion Reports Fourth Quarter and Full Year 2023 Financial Results

– FY23 U.S. Net Product Revenue Grew 40% Y/Y to $78.3 Million; FY23 Total Revenue Grew 54% Y/Y to $116.3 Million – – Q4 U.S. Net Product Revenue Grew 39% Y/Y to $20.8 Million; Q4 Total.

Hong kongUnited statesCzech republicAlexis callahanDaiichi sankyo asiaDaiichi sankyo europeSheldon koenigTiffany aldrichEsperion therapeutics incAmerican heart association scientific sessionsNational health insuranceExchange commissionProduct revenue grewRevenue grewPrescription equivalents grewMomentum expected

Esperion Therapeutics, Inc : Esperion Reports Fourth Quarter and Full Year 2023 Financial Results

Esperion Therapeutics, Inc : Esperion Reports Fourth Quarter and Full Year 2023 Financial Results
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Hong kongUnited statesCzech republicAlexis callahanTiffany aldrichDaiichi sankyo europeDaiichi sankyo asiaSheldon koenigNational health insuranceEsperion therapeutics incExchange commissionAmerican heart association scientific sessionsProduct revenue grewRevenue grewPrescription equivalents grewMomentum expected

Esperion Reports Second Quarter 2023 Financial Results

– Q2 U.S. Net Product Revenue Grew 49% Y/Y to $20.3 Million – – Q2 Retail Prescription Equivalents Grew 26% Y/Y; Q2 New to Brand Prescriptions Grew 28% Q/Q – – Submitted Applications for.

United statesTiffany aldrichAlexis callahanSheldon koenigStephenj nichollsKausikk rayAmerican diabetes associationExchange commissionEuropean medicines agencyDrug administrationEndocrine society meetingJournal of the american medical associationEuropean society of cardiologyProduct revenue grewPrescription equivalents grewBrand prescriptions grew

AGS REPORTS FIRST QUARTER 2023 RESULTS

First Quarter 2023 Highlights: Total Revenue Increased 14% Y/Y to a Record $83.2 Million; Up Sequentially for the Ninth Straight Quarter Net Loss Improved Y/Y.

United statesUnited kingdomKimo akionaDavid lopezJulia boguslawskiBrad boyerBritish columbia lottery corporationPrnewswire playags incSecurities exchangeExchange commissionUs supreme courtInternational gaming operationsPlayags incCompany overviewFirst quarterRevenue increased